Camel colostrum helps in Low Platelet Count induced by any Viral Fever and cancer related treatment

To Evaluate the Effect of Camel Colostrum in Thrombocytopenia patients induced by Viral fever and Cancer related treatment A Multicenter Global Trial. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085256

Enrollment

300

Registered

2025-04-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B349- Viral infection, unspecified

Interventions

Intervention1: Camel colostrum powder- Freeze dried: Camel colostrum powder Dose:10 gms (2 teaspoons) Twice a day for 1 month Duration: 1 month Control Intervention1: NONE. Control group (arm) will no

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male or female patients of age above 10 years. 2.Confirmed clinical diagnosis of thrombocytopenia which is induced by viral fever and cancer related treatment which is confirmed by complete blood count

Exclusion criteria

Exclusion criteria: 1.Patient who is having Lactose Intolerance (Allergic to milk). 2.Those who are Pure Vegan (Not taking any animal product including milk and milk products). 3.CKD 4.Pregnant females

Design outcomes

Primary

Measure	Time frame
Increasing trend of platelet countTimepoint: 1 month	—

Secondary

Measure	Time frame
Increase in platelet count in 3 months, primary outcome will be checked for 1 month & secondary outcome for 3 months.Timepoint: 3 month	—

Countries

India, Kenya, United Arab Emirates

Contacts

Public ContactDr Swati Khartode

Vishwaraj Hospital

opd@vrhpune.com9767133699

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026